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ABSTRACT 
 
BACKGROUND 
 Patient and Parents (Caregivers) Involvement forms the corner 
stone of management of chronic diseases such as diabetes. 
 
OBJECTIVES 
1) To assess the problems of Home based Insulin Therapy in Type I 
Diabetic Children less than 12 years. 2) To assess the impact of 
counseling on correction of error during home based insulin 
therapy. 
 
METHODS 
 Home based Insulin therapy patients are counseled in the form of 
oral and video demonstrations, Interacting sessions and clarified the 
doubts in our hospital. 3 visits in three months interval.  Total No of 
Patients 50.  
In front of observer, patient load the Injection, during the 
procedure which of the following things are observed and recorded in 
proforma. 1) Order of loading 2) Accuracy of dose 3) Pre skin cleaning 
prior to injection 4) Skin pinch 5) Needle angle 6) Lime rotation 7) Site 
Rotation 8) Site related problem and blood drawn for check the level of 
Hba1c.  Those patients pre and post counseling data entered and 
compared results are statistically analysed. 
RESULTS 
 According to the study problems of home based insulin therapy 
are. 1) SMBG frequency 2) Accuracy of dose 3) Skin pinch 4) Needle 
angle 5) disposal of syringe 6) Local site problems 7) Site rotation and 
HbA1c. 
Non Problematic area 
 Non Problematic areas are order of loading of insulin, pre skin 
cleaning, limb rotation. 
 Counseling and demonstration resulted in statistically significantly 
improvement seen.  This emphasis the need for continued counseling and 
demonstration on all visits to the diabetic clinic. 
CONCLUSION 
 The problems of home based insulin theraphy are identify namely. 
1) SMBG frequently 2) Accuracy of the dose 3) Needle angle 4) Skin 
Pinch 5)Local Site problem 6) Site rotation and HBA1c control. 
 The problems are improved significantly with counseling and 
demonstration. Hence the need for continue diabetic education is obvious.   
This study emphasis the need for counseling by qualified personnel 
devoting plenty of time with demonstration improve quality and 
longevity of life and Juvenile diabetes.  
Key words : type 1 diabetes mellitus, home based insulin theraphy, 
counseling, diabetic education. 
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INTRODUCTION 
 Diabetes mellitus1 is a common chronic metabolic disease with 
hyperglycemia as the cardinal biochemical feature.  Diabetes is classified 
according to the cause.  First  type is deficiency of  insulin secretion due 
to beta cell damage in pancreas (Type 1 DM) and, second one  is  
consequence of  insulin  resistance occurring in skeletal muscle, liver and 
adipose tissue along with various degree of  beta cell impairment      
(Type 2).  Most common endocrine metabolic disorder of adolescent and 
children is Type 1 DM with marked consequences of physical and mental 
development, and also Type 2 DM is increasingly diagnosed in youth. 
According to International Diabetic Federation2 (IDF), 366 million 
people are living with DM resulting in prevalence rate of 8.3%.  In this 
Type 1 DM accounts for 10-12 % of overall Diabetic patients. In our 
country, prevalence rate is 10.1 – 10.6 / 1,00,000 population, higher 
prevalence in urban than rural area. Among them men (11.56 / 100000) 
have higher prevalence than women (8.6 /100 000). Nowadays the 
prevalence of Diabetes is increasing globally as well as in India.  
Incidence of diabetes increase by 3% per year globally.      
 Diabetes is not a single entity. It is a heterogenous  group of 
disorder  in which  distinct  genetic  pattern  as  well as other  etiological   
factors  and pathophysiological  mechanisms  interact leading  to  
impairment  of glucose  tolerance. 
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Classification of diabetes mellitus according to etiological causes:  
I.TYPE 1 Diabetes (β cell destruction leading to absolute insulin 
deficiency) 
A. Immune mediated 
B. Idiopathic  
II.TYPE 2 DIABETES (predominantly insulin resistance with insulin 
deficiency, with minimal resistance)   
III.OTHER SPECIFIC TYPES       
A. Beta cell function defect (Genetic)  
MODY 2 
MODY 3 
MODY 4 (Insulin promoter factor 1) 
MODY 5 (HNF 1 BETA) 
MODY 6 (NEURO D1) 
MITOCHONDRIAL DNA 
TYPE A INSULIN resistance 
Lipoatropic diabetes 
Leprechaunism 
Beta cell action defect (Genetic) 
RABSON Mendenhall syndrome 
Others     
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B. Genetic defects in insulin action 
C. Diseases of exocrine pancreas 
D. Endocrinopathies        
E. Drug /chemical induced     
F. Infections 
G. Uncommon forms 
H. Genetic syndromes associated with diabetes 
 
IV. GESTATIONAL DIABETES 
 Criteria to diagnose diabetes - 
(According to American diabetic Association criteria3)  
1. FPG (fasting plasma glucose) > 126 mg /dl (7 mmol) (nil per oral > 
8 hours). 
2. 2 hrs PG > 200 mg/dl (11.1mmol/l) (during OGTT 75g 
GLUCOSE). 
3. HBA1C > 6.5 % (perform lab using NGSP CERTIFIED METHOD  
AND  standardized to  DCCT assay). 
4. RANDOM PG > 200 mg/dl (11.1mmol/l) in person with  
symptoms of hyperglycemia (if the  hyperglycemia is  equivocal  
repeat the test). 
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Diagnostic criteria for IGT (impaired glucose tolerance)   
1. FBG 100-125 mg/ dl (5.6 -7.0 mmol/L)    
2. 2 HOURS  PLASMA GLUCOSE(  oral glucose tolerance test )  > 
140 mg/dl   but < 200 mg/dl (11.1 mmol/L)    
Impaired glucose tolerance is a metabolic state between normal 
glucose homeostasis and diabetes. Many IGT individuals are euglycemic 
in their normal daily lives with normal or near normal HBAIC levels. 
Hyperglycemia   manifests when only challenged with oral glucose used 
in the standard oral glucose tolerance test.     
IGT  is not a clinical entity  but rather a risk factor for  future  
Diabetes mellitus and cardio vascular diseases and it is often associated 
with insulin resistance, obesity  particularly abdominal or visceral 
obesity, dyslipidemia of triglyceridemia  or HDL /LDL type   or both  and 
hypertension. Insulin resistance is directly involved in pathogenesis of 
TYPE 2 diabetes.      
Type 1 diabetes is characterized by low or absent level of endogenous 
insulin secretion.  
It has 4 distinct stages      
1. Pre Clinical beta cell auto immunity along with progressive defect 
in the insulin secretion. 
2. Onset of the clinical diabetes mellitus    
3. Transient remission  ‘honey moon period’  
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4. Clinical diabetes associated with complications either acute or 
chronic and decreased life expectancy.    
 The predominant age of onset of childhood diabetes is 7   to 15 
years, but may present at any age. The incidence of type 1 DM increased 
worldwide every year by 3 %. In type 1 DM both genetic & 
environmental factors involved in pathogenesis. Susceptibility to TYPE 1 
Diabetes is genetically controlled by alleles of MHC                        
(Major Histo compatibility  complex)  class 2  gene expressing  HLA 
(Human Leukocyte Antigen) and also associated with  autoantibodies  to 
ICA (Islet cell of cytoplasm), Insulin and auto antibodies to GAD 
(Glutamic Acid Decarboxylase).      
  
TYPE 1 DM also associated with some auto immune diseases like    
1) Thyroiditis  
2) Multiple sclerosis 
3) Celiac disease   and  
4) Addison disease  
In TYPE 1 DM, girls and boys are equally affected in younger age 
groups.  The incidence of TYPE 1 is high in male population of Europe 
origin, and where as low incidence in non Europe origin and a female 
preponderance is noted after puberty F: M   > 1.5 in Europe.  
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GENOTYPE  
 90 TO 95 %   of young  children  in TYPE 1 DM4  carry either one 
or both susceptibility haplotypes, 5% with HLA - conferred genetic 
susceptibility develop clinical DM. Risk of DM is 2 % when mother is 
diabetic, but when father is diabetic, risk increases to 7%, In monozygotic 
twins  risk is 30 – 65 % but in dizygotic twins risk is only 7- 10 %.  Most 
of the Type 1 DM patients don’t have single gene defect, classical single 
gene defect is extremely rare. Risk of developing DM is modified by the 
influence of several risk loci. Great contribution to the risk is from HLA 
on chromosome 6, other region is promoter region 5 of insulin gene on 
chromosome 11 and also several other loci involved like PTPN2, 
PTPN22, Interleukin -2 receptor CD25, CTLA 4, ERBB 3e, in which 
PTP N 22 has less useful in predicting genetic risk of TYPE 1 DM. Other 
risk factors identified in epidemiological studies, operate in early life and 
trigger the immune mediated process in genetically risky patients. Timing 
of introduction of cereals / gluten and other foods to infant diet alter risk 
of autoimmunity & T1 DM. Increasing the use of supplementation of  Vit 
D reduces risk of T1DM. High maternal consumption of Vit D during 
pregnancy reduce the risk of islet autoimmunity, also protective effect 
observed in serum alpatocopherol in TYPE 1 DM 
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PATHOGENESIS OF DIABETES MELLITUS 
 TYPE 1DM in a susceptible host develops autoimmunity against 
their own  beta cells, but what triggers  the auto immune  response is not 
known. In some of them, auto immune response results in progressive 
destruction of beta cells until critical level of mass lost and deficiency of 
insulin develops. Deficiency of insulin leads to onset of clinical signs and 
symptoms of diabetes. In some of patients some amount of viable beta 
cells are present and that produces enough insulin and leads to partial 
remission of the disease (known as honey moon period).  
 Over a period of time nearly all beta cells are destroyed and the 
patient depends on exogenous insulin.  Then over a period of time some 
of the patients develop secondary complication of diabetes mellitus that is 
proportionate to how well they control the disease.    
  
COURSE OF THE DISEASE   
The following stages are seen- 
1. Auto immunity initiation  
2. Pre clinical auto immunity and progressive loss of beta cells  
3. Clinical onset of diabetes with signs and symptoms 
4. Transient remission of diabetes     
5. Clinically established disease  
6. Development of complication of disease  
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CLINICAL ONSET OF DIABETES    
90 % of beta cell mass is destroyed at the time of clinical disease.  
Beta cell destruction is more rapid and complete in younger children, 
while older age group and adults have high percentage of beta cell 
preserved (10 to 20%) compared to younger age groups. The surviving 
mass of beta cells present at the time of diagnosis is important in newly 
diagnosed case  because  it  increase the possibility of secondary 
prevention in TYPE 1DM.       
  
PATHOPHYSIOLOGY OF TYPE 1 DIABETES  
Insulin plays a major role in storage and retrieval of cellular fuel. 
Insulin secretion in response to feeding is modulated by interplay of 
neuronal, hormonal and   substrate level mechanisms. Insulin level both 
in anabolic state and in catabolic state will affect the liver muscle and 
adipose tissue. Type1DM is a progressive catabolic low insulin state, 
feeding does not reverse this state.  In reverse it exaggerates the state. In 
this state (low insulin catabolic) glucose utilization by liver and muscle 
will reduces and results in postprandial hyperglycemia. Even in lower 
level of insulin, liver produces excess of glucose by glycogenolysis and 
neo glucogenesis, will result in fasting hyperglycemia. Hyperglycemia 
will manifest as osmotic diuresis when renal threshold exceed 180 mg /dl 
which results in loss of calories and electrolytes as well as persistent 
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dehydration. This leads to stress & produces stress hormones. These 
hormones causes further metabolic decompensation, further reduce 
secretion of insulin. The combination insulin deficiency and increased 
counter regulatory hormones are reasons for lipolysis and impaired lipid 
synthesis and lead to increased level of cholesterol, total lipids, 
triglycerides and free fatty acids. Hormonal interplay of low insulin and 
high level of glucagon shunts free fatty acid to ketone body formation. If 
the formation exceeds the peripheral utilization, that is excreted in urine.  
Accumulation of ketone bodies 
Metabolic acidosis 
 Compensatory rapid breathing 
Dehydration, hyperosmolarity 
 Diminished Cerebral oxygen utilization  
Coma 
 
CLINICAL FEATURES OF TYPE 1 DM 
Diabetics develop symptoms which steadily increases and reflects 
decreasing beta cell mass. When level of glucose is sufficiently high 
above the renal threshold, intermittent polyuria or nocturnal symptoms 
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starts.When chronic hyperglycemia leads to persistent diuresis, polydipsia 
become more prominent. If the affected patient is female, she may 
develop monilial vaginitis due to chronic glycosuria. More calories are 
lost in urine, that trigger hyperphagia. This hyperphagia does not keep in 
pace, with intake loss of fat from the body occurs. 
 In extreme low insulin levels, ketone bodies accumulate and child   
deteriorates quickly. These keto acids produce nausea, abdominal 
discomfort and pain and lead to dehydration. But persistence of polyuria 
& ketoacidosis exacerbate the symptoms such as increased respiration 
which is deep and rapid with fruity odor, reduced neuro cognitive 
function & possibly coma. 1/3 of patients present with DKA   when they 
are not yet diagnosed.       
 
DIANOSIS OF TYPE 1 DIABETES 
Most  of  symptoms  are   non specific,  important symptoms  are     
inappropriate  polyuria  with  dehydration, poor weight gain, non  fasting  
plasma  glucose  level   > 200  mg/dl, along  with  symptom  of  diabetes   
is diagnostic, associated  with  or  without ketonuria. Once hyperglycemia 
is confirmed, it is prudent to check ketonuria present or not with 
electrolyte imbalance.  Estimate the baseline  HBA1C  level    to  identify  
the   duration  of the  disease  also  to  compare  the  effectiveness  of   the  
therapy. In non obese children testing the auto immunity for beta  cells  is  
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not  indicated, other  auto  immunity   associated   with   diabetes   to   be  
investigated. 
1. Thyroiditis (anti thyroid peroxidase, anti-thyroglobulin anti bodies) 
2. Celiac diseases (tissue transglutaminase IgA, and total IgA ) 
          
CRITERIA FOR SCREENIG OF DIABETES 
Risk  of   developing   type 1 DM  screened   by    presence  of  
GADA (Glutamic acid  decaboxylase   auto antibodies) , PIA  (Pancreatic   
Islet auto antibodies , IA-2  (Insulinoma  associated   Auto Antibodies). 
Screening is recommended for family history of type 1 DM in siblings, 
and considers the age of onset, sex, genetic markers and C- Peptide assay. 
ADA  current  recommendation   is  considering   the  referral    of   
relatives  of   Type 1  DM   for  antibodies   testing  and    assessment  of     
the   risk . 
 
RECOMMENTATIONS 
 TYPE 1DM patient’s first degree relatives are screened for   
pancreatic beta cell anti bodies and OGTT also recommended. Also   
annual  measurement  of  thyroid  stimulating  hormone and screening  
the  diabetic   children  for  celiac  disease and other  associated   auto 
immune  disorders. It is also important to monitor the growth and 
puberty.   
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MANAGEMENT OF TYPE 1 DIABETES  
Management  of  type 1 DM    needs   team  approach,  patients and  
family  members   must  be  educated   in self  management of diabetes  
including prevention and first aid  management related to emergencies  in 
this disease, lifelong  insulin  therapy and nutrition  therapy, planned 
physical activity and self  monitoring of blood glucose. Psychological 
problems must be anticipated and addressed in time. Therefore the goal of 
the treatment is to keep the child symptom free, ensure the normal   
growth and development with HBA1C level as close to the normal range  
as  possible. The lower Glycosylated Hemoglobin level, lower the risk of 
development of long term micro /macro vascular complications.  
Regular screening for long term complications and co morbid 
conditions is warranted. Replacement of missing  hormone  insulin  is not 
the  only  aspect of  management  of  DM, also Equal  importance  given  
to   four  thematic pillars and  they  are     
1) Insulin  therapy     
2) Medical   nutrition  therapy  (meal  planning)    
3) Planned  physical  activity 
4) Self  monitoring   of  blood  glucose  and  blood and  urinary   
ketone bodies  
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INSULIN     THERAPY 
Fundamentals of Insulin Management5 
ADA (American Diabetes Association) recommended the   terminology 
1. Basal  insulin 
2. Prandial insulin 
3. Nutritional insulin 
4. Correction insulin used in type I  diabetic management therapy 
 
BASAL   INSULIN 
Needed consistently to prevent the diabetic ketoacidosis 
 
PRANDIAL    INSULIN 
Need to prevent the post prandial raise of blood glucose caused by 
peripheral glucose disposal at the level of muscle. 
 
NUTRITIONAL INSULIN 
Used for instead of prandial insulin when calories provided by total   
parental nutrition or NG feeding. 
 
CORRECTION INSULIN 
This is additional insulin given for correcting the hyperglycemia. 
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In healthy non stress individuals one unit of normal insulin will 
reduce the glucose approximately 50mg/dl (1:50) and one unit of insulin 
will cover 15g of carbohydrate (1:15).  These ratios vary with individual, 
age, sex, pubertal status, weight and general activity. 
 
TYPES OF INSULIN6 
Meal time insulin  
Rapid acting insulin analogues   
1)  lispro   
2)  Aspart 
 
1. LISPRO 
In comparison to regular insulin lispro peaks rapidly, lower the 
post prandial glucose level and prevent hyperglycemia. It is administered   
30 minutes before food. 
 
2. ASPART 
In comparison to lispro, it significantly reduces the HBA1C   and 
but does not cause frequent hypoglycemia     
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SHORT ACTING HUMAN   INSULIN - REGULAR 
It is injected subcutaneously and has slower rate of absorption. It 
has onset of action 15-60 min after injection, peak 2-4 hrs and duration of 
action 5-8hrs. It is given half an hour before meals. 
 
BASAL INSULIN 
Intermediate acting human insulin, has more prolonged action so 
they are not ideal for controlling postprandial glucose level. 
 
LONG ACTING INSULIN 
This is otherwise called as Ultra lente insulin. Most patients require 
only one injection of basal insulin per day at bed time. 
 
MEDICAL NUTRITION THERAPY7 
Medical nutrition therapy provide information, motivation and 
problem solving technique for meal planning and family nutrition for 
children with diabetes. It is a integral component of any any successful 
diabetic self management. 
General nutritional goals for a diabetic child includes; 
1. To reach and maintain the optimal blood glucose level. 
2. To achieve a optimal lipid and lipoprotein level. 
3. To maintain an optimal blood pressure. 
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4. To prevent and treat the complications of diabetes. 
5. To provide adequate calories for the maintenance of  
acceptable weight, normal growth and developmental rates  
of the diabetic children. 
Food and feeding issues are very important part of physical and 
psychological growth of diabetic children. 
Dietary education must be done differently to each children and 
depends on developmental state and family dynamics. The diabetic 
children should have the balance between food, insulin therapy and 
everyday activities as there is already a need for physical maturity.  
Frequent assessment of diet and careful monitoring of growth are 
important aspects of medical nutrition therapy. There can be a wide 
variation of caloric need in children with diabetes. The caloric need 
changes according to work in which child involves,  such as school 
activities, works at home, weekend recreations, vocation and sports 
activities continued nutritional follow up and education are required for 
every 6 months to 1 year.  
Nutritional recommendations for protein, carbohydrate and fat 
content to achieve optimum metabolic control in children with diabetes 
includes 
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1. Amount of fat should not exceed 30% of total calories, in which 
less than 10% from saturated fat, less than 10% from poly 
unsaturated fats and 10-15% from mono unsaturated fats. 
2.  Dietary cholesterol should be limited to less than 300 mg/day. 
3. Carbohydrates and mono saturated fat should contribute to 60-70% 
of meal plan. 
4. 2.2 gram/kg/day of protein should be provided for infants with 
diabetes. 
5. 0.9 gram/ kg /day of protein should be provided adolescents with 
diabetes.     
 
In Indian journal of endocrinology and metabolism, the first indian 
recommendation for best injection practice by Sanjay kalra et al8 and   
First   Indian   Insulin.  Injection  technique   guidelines by FIT (Forum  
for  Injection  Technique) provides important information which is useful 
for self care of diabetic patients to achieve optimal glycemic control. 
NEED   FOR    GUIDELINES: 
Therapeutic success of insulin is highly operator dependent. Factors    
influencing the techniques are following. 
 Modifiable Factors 
 Non Modifiable Factors 
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Modifiable   factors                  Non modifiable factors      
1) Method of administration             1) Visual   impairment 
2) Dosing                                          2) Hearing impairment 
3) Compliance                                 3) Basic   education 
4) Selection   sites                            4) Learning skill 
5) Misconception   about   therapy 
6) Clinician   knowledge   and   time 
The Indian health care practices are mostly hospital or physician 
based rather than guide line based like other developing countries. So the 
need for pre injection evaluation, psychotherapy and counseling. 
          In diabetes mellitus it is important to include the children and 
parents as important partners in this disease care.  Explanation of role of 
insulin in management and need for regular therapy, using simple   
comprehensible words. 
STORAGE OF INSULIN 
Injection is to be stored in room temperature in a dark place       
(15-250C) and discarded after 30 days of initial use, Extremes of 
temperature should be avoided. 
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COMPATIABILITY OF SYRINGE AND VIAL 
It   is   important   to   inject   correct insulin in correct syringe.  
In   our country   both 40u/ml   and   100u/ml   vials are available, 
use 40u vial for   40u   syringe and   100u   vial for 100u   syringe. 
BEST SITES FOR INJECTION 
In diabetic patients insulin is administered subcutaneously in stress 
free condition. Intravenous infusion and intramuscular sites are used for 
stressful condition like DKA. 
ANTERIOR ABDOMEN WALL 
It  is  most  frequent  injection site administered below the straight 
line  2.5 cm  above  umbilicus   and   vertical   line   5cm  away   from  
umbilicus.   
UPPER ARM 
Insulin is administered subcutaneously in Posterior   middle   3rd   
of   arm   between shoulder and elbow 
ANTERIOR THIGH 
Insulin is administered subcutaneously in anterior and outer mid 
third aspect of thigh. The order of rate of   absorption site is abdomen> 
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arm > thigh. There is less presence of   fat and no major nerves in this 
region. 
SKIN   FOLD FOR INJECTION 
Thumb and index finger used to make a fold (along with middle 
finger) and lifted skin fold should not be squeezed tightly.  The sequence 
of lifted skin fold is 
 Make lifted skin fold and insert the needle into skin at 900 angle. 
 Administer the insulin 
 Withdraw needle from skin fold 
 Release the fold 
BARRIER TO INSULIN THERAPY  
The success of home based insulin therapy is based on identifying 
and correcting the barrier. 
BARRIERS IN PATIENT SIDE 
This is corrected by  asking open  ended and non judge mental 
questions  and  help the patient to disclose  their  concern  and implement 
the effective  way  of  management. 
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BARRIERS IN PHYSICIAN 
Physician related barrier is delay in initiating the insulin in time 
and concern about delay in identifying the adherence, hypoglycemia and 
weight gain and other minor factors.  Lack of support of paramedical 
workers like diabetic department trained staff also acts as a barrier. 
GOALS OF INSULIN THERAPY 
1. Free  from symptoms of  hyperglycemia 
2. To  prevent diabetic ketoacidosis 
3. To assess severe catabolic state and regain lean body mass, reduce 
the frequency of injection, to prevent   and delay the micro/macro 
vascular complications. 
 
Calculate total daily 
insulin(TDI)=0.5units  x 
weight (kg) 
 
 Total meal time 
insulin =60% of TDI        
 Total basal 
insulin=40% of TDI 
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If a patient is newly diagnosed type 1 DM usual daily insulin 
requirement is 0.5 to 0.7 units /kg/day.  Half of the dose should be given 
as basal insulin and reminder as prandial insulin. 
 
MEDICAL   NUTRITION   THERAPY 
As recommended by American diabetes Association goals in type 1 
diabetes.  
i. Individualized meal plan  based on usual food intake and life 
style.   
ii. Consistency of carbohydrate intake to allow synchronization of 
meal times  with fixed time of insulin  regimens. 
iii. Determination of insulin dose and post prandial glucose level 
monitoring and adjust the insulin dose.  
iv. Prevention of weight gain.   
v. Adjustment of rapid or short acting insulin according to food 
intake. 
 
EDUCATION    IN   TREATMENT   OF   DIABETES 
Improve the well being and quality of life, also improve self care 
practices. But psychological factors should also be given importance. 
i. Emotional   based coping  styles. 
ii. TYIDM   related   distress. 
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iii. Lack  of  readiness  to  change. 
iv. Positive  emotional  outlook  about  diabetes. 
 
 METABOLIC CONTROL  
DCCT  (Diabetic  control  and  complication  trial)  and  UKPDS   
(United  kingdom prospective diabetes study) were the two studies, 
conducted to evaluate the importance of good glycemic control. Both 
these studies had established the  importance  of  good  glycemic  control  
in    reducing  the  short  and  long  term  complications. 
Multidisciplinary team includes health care Practitioner / Educator 
& Nutritionist.  The  role  of  other  team  members   like   psychologist,  
pharmacist,  ophthalmologist are  now  being  recognized well.  
 
PREVENTION AND EARLY DETECTION OF COMPLICATIONS 
Diabetic education plays the major role in the prevention and early 
detection of complications of type 1 DM. Studies have confirmed that 
patients who  do  not  receive   the  education  were  at increase  risk  of  
complications. Further  self  management and  insulin  skills  depends   on  
diabetic  education  which also  has  protective effect on risk of 
complications. 
Diabetic education programs are evolving as a part and 
multifaceted diabetic management efforts provided by skilled health care   
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team that help the patients to reach high level of adherence and metabolic 
control. Diabetic patient education services should be accessible to every   
diabetic patient. 
 
COMPLICATIONS OF TYPE I DM 
Complications can be classified as acute, intermediate and chronic 
complications. 
 
ACUTE COMPLICATIONS 
1. Diabetic ketoacidosis 
2. Hypoglycemia 
 
INTERMEDIATE COMPLICATIONS 
1. Lipoatrophy. 
2. Limited joint mobility 
3. Growth failure 
4. Delay in sexual maturation 
5. Hypoglycemic unawareness 
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CHRONIC COMPLICATIONS 
1. Retinopathy 
2. Peripheral neuropathy 
3. Nephropathy 
4. Dyslipidemia 
5. Celiac disease 
 
DIABETIC KETO ACIDOSOSIS 
This is the most severe complication of Type 1 diabetes mellitus 
and characterized by hyperglycemic dehydration and associated ketotic 
acidemia. It results from a state of insulin deficiency and most common 
cause of diabetes related deaths in Type 1 DM. Diabetic ketoacidosis is 
because of a decline in circulating insulin levels and a related increase in 
counter regulatory hormones like glucagon, catecholamines, cortisol and 
growth hormone and usual precipitating factors includes unusual physical 
stress, infection, or in known diabetic patients omission of insulin 
injections. 
Typically blood sugar level is above 250 mg /dl, ketones positive at  
>1:2 dilution, serum pH is less  than 7.3 and serum bicarbonate is less 
than 15 m.eq/ l. The biochemical criteria for the diagnosis of DKA 
include. 
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1. Hyperglycemia :  Blood glucose more than 200 mg/ dl. 
2. Venous pH less than 7.3 or bicarbonate less than 15 mmol/litre. 
3. Glycosuria, ketonuria and ketonemia. 
 
CATEGORIZATION OF SEVERITY 
  Categorization of severity depends on the acidosis observed in 
DKA. 
1. MILD VARIETY 
Venous pH is between 7.20 to 7.30 and bicarbonate level is 
in between 10 to 15 m.mol/litre. 
2. MODERATE VARIETY 
Venous Ph is between 7.10 to 7.30 and bicarbonate level is 
in between 5 to 10 m.mol/litre. 
3. SEVERE VARIETY 
Venous Ph is less than 7.10 and bicarbonate level is less than 
5 m.mol/litre. 
 
CLINICAL PRESENTATION 
DKA can present as a primary presentation of type 1 DM and 
around 15 to 70% of all newly diagnosed patients present with DKA. The 
overall rate of DKA in type 1 DM patient remains as 25%. The 
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prevalence of DKA decreases from 36% in aged less than 5 years to 16% 
in aged more than 14 years old. 
 DKA is most frequently observed in children who were non-
compliant to insulin therapy. Patients using insulin pumps are more prone 
to DKA  as malfunction of pump may lead to interruption in insulin flow. 
Sometimes it presents as a case of acute abdomen. The most common 
symptoms are abdominal pain, nausea, vomiting, polyuria, dyspnoea and  
polydipsia. 
 The physical examination may reveal  
 Tachycardia 
 Dry mucous membranes 
 Reduced skin turgor 
 Hypotension 
 Tachypnoea 
 Kussmaul respiration 
 Respiratory distress 
 Abdominal tenderness 
 Lethargy 
 Cerebral edema 
 Coma 
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In all patients a precipitating factor should be sought. Infection is 
the most common precipitating factor. The metabolic derangements may 
take long time to develop, but the symptoms and signs develop within 24 
hours.  
COMPLICATIONS OF DKA 
1. Cerebral edema (most dreaded and a fatal complication) 
2. Hypokalemia 
3. Hypoglycemia 
4. Septic shock 
5. Cerebral hemorrhage or thrombosis. (DKA is prothrombotic state)        
6. Pancreatitis 
MONITORING AND INVESTIGATIONS 
 Admission is intensive care unit is necessary in children with 
moderate and severe categories of DKA. 
 Hourly monitoring of heart rate, respiratory rate, BP, SpO2. 
 Hourly input and output chart. 
 Hourly pupils and neurological examination is necessary for 
warning signs and symptoms of cerebral edema.This includes head 
ache, increasing BP, bradycardia, vomiting, restlessness, 
irritability, drowsiness, incontinence, cranial nerve palsies and 
unequal pupils. 
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 Hourly blood glucose level. If capillary blood glucose is used cross 
checking with venous glucose value is necessary as CBG is not 
accurate in poor peripheral circulation. 
 2 to 4  hourly blood gases and electrolytes. 
 8 to 12 hourly urea and hematocrit. 
 
MANAGEMENT 
1. Correction of dehydration 
Though dehydration is seen in all patients, shock is rare 
because of the hyperosmolar state which results in fluid shift to 
maintain the intravascular volume. Counter regulatory hormones 
like cortisol also helps to maintain the BP. 
If shock is present resuscitation with boluses of 10 ml/kg of 
0.9% saline over 30-60 minutes. Initial boluses are not necessary 
for dehydration without shock. The degree of dehydration is 
generally 5-8%. Rehydration should be achieved with NS that is 
infused over 48 hours. 
2. Correction of acidosis and bicarbonate therapy 
DKA patients have a wide anion gap metabolic acidosis because 
of presence of excess ketones and lactate. Fluid replacement with 
insulin therapy will effectively correct acidosis. Majority of 
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patients do not need bicarbonate therapy. However indications for 
bicarbonate therapy are infrequent and includes 
1. Severe acidosis 
2. Refractory shock 
3. Life threatening hyperkalemia 
The required dose of bicarbonate (in m.mol) is calculated by 
following formula      0.3 × ݓ݁݅݃ℎݐ ݅݊ ݇݃ × ܾܽݏ݁ ݂݀݁݅ܿ݅ݐ 
Half of the calculated dose should be infused over 4 hours then 
again patients ABG  should be checked. Stop bicarbonate therapy when 
Ph is more than 7. 
 
POTTASIUM REPLACEMENT 
 This should be started before the commencement of insulin 
infusion.  
 
INSULIN INFUSION 
 Initial bolus of insulin is not required and should be given as a in 
fusion through a dedicated iv line. IV line needs to be primed with insulin 
containing solution, as insulin may bind with this tubings. Infusion should 
be started at the rate of 0.05 to0.1 units/kg/hr. 
  Aim for the fall in blood glucose level is 100 mg/dl/hr. 
Titrations should be done in infusion rate to keep the blood glucose level 
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between 100-200 mg/dl.It can be stopped when the child is alert and 
metabolically stable. 
 
SODIUM REPLACEMENT 
Hyponatremia is factitious or translocational hyponatremia. A 
corrected sodium level should be obtained.If corrected sodium is above 
150 meq/litre it means a hypernatremic and independent glucose 
hyperosmolol state exists. 
 
CEREBRAL EDEMA 
Risk factors include 
1. Severe hypocapnia at presentation. 
2. Increased serum urea nitrogen at presentation. 
3. Failure of measured serum sodium concentrations to rise during 
therapy. 
4. Severe acidosis at presentation. 
Should the evidence of brain herniation to develop the time for 
effective therapy is short short. If doubt arises patient should be intubated 
and osmolar therapy should be started. Mannitol 1-1.5 g/kg iv infusion or 
3% hyper tonic may be used to increase the serum osmolality by 5-10 
mOsm/kg and to decrease cerebral edema. 
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 Mortality rate in paediatric population varies between 0.15 to 
0.3%.Cerebral edema  is related with 60-90% of deaths related to DKA. 
 
LIMITING FACTORS OF GLYCEMIC CONTROL 
Glycemic control reduces the microvascular complications like 
nephropathy, neuropathy, retinopathy also may reduce macro vascular 
complications. 
Iatrogenic hypoglycemia is the limiting factor for glycemic control.  
Euglycemia is not glycemic goal in treatment of type1 diabetes but the 
goal is lowest mean glycemia that may not cause severe Hypoglycemia 
and allows continuous awareness of hypoglycemia.   
Falling   blood   glucose   level  is  a  signal  of  series  of  response, 
includes  decrease  insulin  secretion  as  glucose  level  is  low  and 
increase  in  glucogan,  Epinephrine  secretion  and  produce  more  
sympathoadrenal  response   with  glucose  level  50  to  55mg/dl  more  
recent  reports   shows  that  6%  to  10%  of  death in  people  with  
T1DM,  are   due  to  hypoglycemia. 
According to American diabetes association (ADA)  
Hypoglycemia  defined in Ty I DM patient,  “Every episode of  abnormal 
low plasma glucose concentration that exposes the potential harm to the 
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individual   that include both symptomatic and asymptomatic 
hypoglycemia’’.   
 
ADA (American Diabetic Association) also classifies the 
hypoglycemia as follows. 
1. SEVERE  HYPOGLYCEMIA 
Severe hypoglycemia is defined as a hypoglycemic episode that  
need another person to increase the blood glucose level and  
neurogenic  recovery. 
2. DOCUMENTED SYMPTOMATIC  HYPOGLYCEMIA  
 This is defined as an episode of hypoglycemia that is not associated 
with characteristic symptoms of hypoglycemia but with a finding of 
blood glucose level less than 70 mg/dl. 
3. ASYMPTOMATIC HYPOGLYCEMIA  
This is defined as without any symptoms, only low blood glucose 
level.  
4. PROBABLE SYMPTOMATIC HYPOGLYCEMIA 
This is an episode of hypoglycemia in which characteristic 
symptoms of hypoglycemia are not accompanied by a blood glucose 
level determination but symptoms were presumably because of blood 
glucose level less than 70 mg/dl 
5. RELATIVE   HYPOGLYCEMIA.  
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PRIMARY PREVENTION OF TYPE 1 DIABETES  
 A safe, effective, inexpensive, easy intervention could be 
theoretically targeted to all new born, but still now there is no universally 
accepted method.  But delaying the introduction of cow’s milk and 
cereals and prolonging the duration of breast feeding all methods are 
potentially beneficial trials and interventions are going. In high risk group 
people, especially with high risk genotype, parenteral and nasal insulin 
are proved equally not effective to prevent the diabetes but oral insulin 
appear to delay in incidence of diabetes in some patients, trials are 
currently going on . 
   
SECONDARY PREVENTION   
 Type 1 DM is a T cell mediated immunity, start from 3 to 5 years 
before appearance of the clinical disease and continue after   the diagnosis 
of TYPE 1 DM and effector mechanism is the cause for destruction of 
beta cell, involve cytotoxic T cells and soluble T cell products. 
Depending on the age  20 % TO 40%  of beta cells are intact at the time 
of diagnosis and 1% of beta cells  secretes even after 30 years of 
diagnosis  This  process lead to possibility of diabetes can  be cured and 
ameliorated by stopping the auto immune destruction after initial 
diagnosis of type 1 diabetes (secondary prevention ).   
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REVIEW OF LITERATURE 
1.Irentibierg et al9. conducted a randomized control study in 117 
newly   diagnosed type 1 diabetes mellitus patients, aged 3 to 15 years. 
They compared the two groups Hospital Based Home care(HBHC)group,  
Hospital  based care group. In HBHC group, HB A1 C levels were 
slightly higher but the mean value of parent satisfaction was higher, mean   
value of hospital stay lower and health care cost was 30 % lower. Further 
HBHC children showed lower mean glucose value and lower variable    
than in hospital based group.  Fewer episodes of hypoglycemia were 
noted in HBHC group when compared to hospital based group. 
(significant p value < 0.001). After one month of trial  they concluded  
that  HBHC group  as being a safe  and  cost effective way to make 
available  the care  in  non ill patients. 
2.Subishpalaian and Leelavathy10 conducted study about  
knowledge, attitude,  and  practice and outcome of evaluating the impact 
of  counseling   in  Hospitalized   diabetic   patients  in  India.  In total 46   
patients 27 were in control group and 19 patients in test group in   
diabetic specialized kasturiba hospital from November 2002 to April   
2003. They counselled about the diabetes and life style modification in   
terms of knowledge, attitude, and practice at bed side over 60 minutes   
and sharing of leaflet till the hospital stay and review after 2 months at 
 36 
 
fixed intervals. In this study to evaluate the consequence of the 
counseling in diabetic patients done by pharmacist and concluded that,    
counseling improves the knowledge but not the attitude and practice. The 
limitation of the study is that it did not to evaluate the compliance of   
diabetic patients and study group is tiny. 
3.Berhave seyoum et al11. conducted  a descriptive  study   in  
department    of  internal  medicine, Addis Ababa  university, Ethiopia. 
He enrolled 100     diabetic  patients  who  were on insulin therapy  and 
observations shown  53 patients  had  Hyper pigmentation  at  injection 
site and 30 patients   had indurations and  31patients had hypertrophy .   
He concluded that illiteracy was considerably associated with local 
site  complication ( p value < 0.05 ),  and also fasting blood glucose mean  
value is high ( p value  <0.001 )  in patient without local complications . 
He did not find  any disproportion in the duration of  diabetes , frequency  
of  hypoglycemic episodes(p value > 0.05) and also  this  study concluded 
that local site complication result from incorrect technique and   
disfigurement may compromise the compliance, so that inspection of  the  
injection  site  is often needed to detect and correct the defective  
technique . 
4.De Villiers et al12. conducted a descriptive study in department 
of pediatrics and child health university of Limbobo. He included 23 
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diabetic patients of different age group from 6 to 18 years old, to see the 
prevalence of lipohypertropy in pediatric diabetic patients. He found 
significant correlation between lipohypertropy and number of visits for 
review. He also found that 52% of diabetic patients had 
lipohypoypertropy and  80 %  patients  among  them  are  frequently  
examined  for  lipohypertropy.. It  does not occur in  first  year of  
diabetic life, in  50% of the patients  developed during the 2nd year  and  
30 % patients  developed on the  5th  year .Finally he concluded that 
lipohypertropy is not easy to recognize, it  needs wide-ranging education. 
Identification of lipohypertropy need physical examination by palpation, 
not only by inspection. 
5. Christopher f. jasinki and Rosa Rodriguez-monguio13 
conducted a retrospective cross-sectional study including 84 patients in 
age group 1to 18 years from the Baystate hospital for children to evaluate 
the metabolic outcome, health care utilization and cost in type1diabetic 
patients comparing those educated in hospital based group and who are 
all treated in outpatient   group. 
He found  that  the average  health care utilization of the inpatient  
group  is 2.6 higher than that of outpatient (group p value <0.001), the 
average charge for diagnostic test for in patients were significantly higher 
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in inpatient group than outpatient  group  and  there  is  no  major  
difference of  mean  value  of  HBA1C  in  both  the  group. 
The limitation   of this  study   is  potential of  selection  bias which 
is  common in all non  randomized  control  study  and  this study  
concluded  that with hospital admission for type 1 diabetic care and 
learning , insulin  management training  in new onset of  diabetes  
patients  who are non critically ill does not result in better metabolic 
outcome during the first  year of post diagnosis. 
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STUDY    JUSTIFICATION 
Not much literature exists on home based insulin therapy in 
children with type1 diabetes from India. Also there are limited support 
groups for children with type1 diabetes. Children from lower socio 
economic group have limited access to frequent blood glucose 
monitoring, and frequent counseling session for regular therapy, unless 
they attend the center with facilities for pediatric diabetic care. In this 
scenario, we decided to evaluate the home based insulin therapy related 
problems and the impact of repeated counseling session in rectifying the 
same. 
 The outcome of the study may help to evaluate the usefulness of 
counseling package used and also help to revise the counseling   
frequencies at diabetic clinic. 
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OBJECTIVES OF THE STUDY 
 
 To assess the problems of home based insulin therapy in type1 
diabetic children less than 12 yrs. 
 
 To assess the impact of   repeated   counseling on correction of errors 
during the home based insulin therapy.  
 
 
 
 
 
 
 
 
 
 
 41 
 
METHODOLOGY 
STUDY   DESIGN   :  Descriptive study 
STUDY   PLACE     : Diabetic clinic and   medical wards of ICH 
STUDY PEROID: Protocol formulation - August 2013 to October 2013 
 Data collection           - October2013 to July 2014 
 Data analysis and       - Aug 2014 to September 2014 
 Manuscript preparation: 
 Submission of report - October 2014 
STUDY POPULATION: 
Inclusion criteria 
All diabetic children more than 1 year within 18 months of 
diagnosis, attending the diabetic clinic of ICH / admitted in ward 
within study period. 
Exclusion criteria 
None. 
Sample size 
All children satisfying inclusion criteria attending diabetic 
clinic in the specified period. 
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STUDY MANEUVER 
 All children satisfying inclusion criteria were recruited from   
diabetic clinic OPD and wards in ICH, Egmore. Children recently 
diagnosed to have   diabetes in the past 18 months were recruited. Age, 
gender, diabetic age, caregiver or parental educational status was   
recorded in the prescribed proforma. 
Initial evaluation was done to assess the technique of home based   
insulin therapy. Evaluation    covers   the   following    parameters                                    
1) Loading of insulin 
 Order of loading 
 accuracy of the dose 
2) Injection technique 
 Pre skin cleaning 
 Appropriate skin pinch 
 Needle angle 
3) Limb rotation 
4) Site rotation     
5) Disposal of  syringe 
6) Local site complication and the level of diabetic control   
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 Once the baseline data were collected, the child’s care giver was to 
undergo the counseling package in the form of oral and video   
demonstration. 
All the children were provided the glucometer, glucometer strips, 
insulin, and insulin syringe in the diabetic clinic. They were followed up 
in 2 visits   at 3 months interval. 
At each schedule visit, the injection procedure was observed for 
any errors, data recorded, followed by counseling session and blood was 
drawn for HBA1C estimation. The same process was repeated on each 
visit.   
ETHICAL CONSIDERATIONS 
 Ethical clearance was obtained prior to starting the study. Every 
patient was included in the study after obtaining informed consent from 
the parent. Strict confidentiality of data was maintained throughout. 
STATISTICAL ANALYSIS 
Data was entered in excel sheet. Qualitative variables were 
expressed as proportion; quantitative variables were converted into 
categories and again expressed in proportion. The change of all 
parameters before and after counseling was analyzed using chi–square 
test. Statistical significance was considered when the p value was <0.005.   
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RESULTS 
 
Total   of  50  patients  were  included in  this  study and came for 
the first visit ,out of  which 48 patients  came  for the second  visit  and  
only  45 patients  attended   third  visit. 
 
 
                      Overall the follow up rate was 90%. 
 
 
 
 
 
 
VISIT I (n=50)
Baseline parameters noted and counselling done 
VISIT II (n=48)
Parameters noted and counselling given
VISIT III (n-45)
Parameters noted
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TABLE : 1 
 
AGE DISTRIBUTION 
 
 
  
 
 
 
 
 
Most common age group recruited in this study was 5 to 9 years, 
which constitutes 60 % followed by >9years who constituted 30% while 
children <5 years of age constituted the minimum, i.e. 10%. 
 
  
Age category Frequency Percentage 
< 5 years 5 10 % 
5-9 years 30 60 % 
> 9 years 15 30 % 
Total 50 100 % 
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AGE DISTRIBUTION  
 
 
 
 
 
 
 
 
 
 
 
 
This chart shows the age group distribution in the study.   
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TABLE : 2 
 
 
GENDER DISTRIBUTION 
 
Sex Frequency Percentage 
Male 18 36 % 
Female 32 64 % 
Total 50 100 % 
 
In this Study there were more patients in female sex than male sex, 
64% as against 36%.  
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GENDER DISTRIBUTION - CHART 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This pie chart shows the gender distribution of patients in this 
study. 
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TABLE : 3 
 
BODY MASS INDEX 
 
This table shows the body mass index of children involved in this 
study.  
Most children (90%) have normal body mass index, followed by 
possible risk of overweight   which   is 6% percentage. Only 2% of 
children fall in overweight and obese category. None of the children were 
in under nutrition category.  
BMI category Frequency Percentage 
Obese 1 2.0 % 
Over Weight 1 2.0 % 
Possible  Risk of Over Weight 3 6.0 % 
Normal 45 90.0 % 
Total 50 100.0 % 
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BODY MASS INDEX - CHART 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chart shows the diagramatic representation of BMI category. 
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TABLE : 4 
 
 
PARENTAL   EDUCATION DISTRIBUTION 
  
Education level Frequency Percentage 
Uneducated 18 36.0 % 
Upto HSc 27 54.0 % 
Graduate 5 10.0 % 
Total 50 100% 
 
 
 Parents of maximum number of children (54%) had completed 
their education upto higher secondary level. 36% were uneducated and 
10% were graduates. 
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PARENTAL   EDUCATION  
 
 
 Given above is graphical depiction of parents’ educational 
status. 
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TABLE : 5 
 
DURATION OF ILLNESS 
 
 
 
 
 
 
 
 
 
 
 
 
Maximum children (68%) were diagnosed to have diabetes 
between 12 and 18 months, followed by 6-12 months (30%) and <6 
months (2%).  
Duration of illness 
(months) Frequency Percentage 
<= 6 1 2.0 % 
6-12 15 30.0 % 
12-18 34 68.0 % 
Total 50 100.0 % 
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DURATION OF ILLNESS 
 
 
 
 
 
 
 
 
 
 
 
This is a diagramatic distribution of duration of illness -In this 
study. 
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TABLE : 6 
 
SMBG – I VISIT 
 
 
This table shows that self monitoring of blood glucose was done 
weekly twice only in 10 % of patients, weekly once in another 58% and 
only occasionally in rest 32% which is very sub optimal. 
       
 
 
 
 
 
SMBG frequency Frequency Percentage 
Weekly Twice 5 10 % 
Weekly once 29 58 % 
Occasional 16 32 % 
Total 50 100 % 
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SMBG - I VISIT - CHART 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This is diagramatic representation of SMBG frequency - In this 
study. 
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TABLE : 7 
 
LOADING OF INSULIN – I VISIT 
 
Method of loading Frequency Percentage 
Right 49 98% 
Wrong 1 2% 
Total 50 100% 
 
 
98 % of parents were correct in the order of loading of insulin on 
their first visit.   
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LOADING OF INSULIN – I VISIT 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This is diagramatic representation of Loading of Insulin – I Visit - 
In this study. 
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TABLE : 8 
 
ACCURACY OF DOSE   INSULIN – I VISIT 
 
 
 
 
 
 
 
 
 
The accuracy of insulin dose loaded was correct only in 30% on 
first visit while majority (70%) were inaccurate in loading the correct 
dosage. 
  
Accuracy of dosage Frequency Percentage 
Right 15 30% 
Wrong 35 70% 
Total 50 100% 
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ACCURACY OF DOSE   INSULIN – I VISIT 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
This is diagramatic representation accuracy of dose Insulin – I 
visit. 
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TABLE : 9 
 
PRE INJECTION CLEANING –I VISIT 
 
Pre injection cleaning Frequency Percentage 
Done 4 8% 
Not done 46 92% 
Total 50 100% 
 
 
There is no need of any pre skin cleaning prior to insulin injection. 
This was understood and practiced correctly by 92 % patients. 
Pre skin cleaning, which was unwarranted was done in only 8%. 
 
 
 
 
 
 
 
 
  
 62 
 
4 (8%)
46 (92%)
Frequency
Done
Not done
CHART : 9 
 
PRE INJECTION CLEANING – VISIT I 
 
 
 
   
 
 
 
 
 
   
 
 
 
This is diagramatic representation of Pre-injection cleaning - First 
Visit. 
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TABLE : 10 
 
SKIN PINCH – I VISIT 
 
Skin pinch Frequency Percentage 
Right 26 52% 
Wrong 24 48% 
Total 50 100% 
 
 
This table shows that skin pinch appropriation at the I visit was 
correct only in 52 % of patients. The other 48% patients were incorrect. 
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SKIN PINCH – I VISIT 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This is diagramatic representation of Skin Pinch - First Visit. 
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TABLE : 11 
 
NEEDLE ANGLE – I VISIT 
  
Needle Angle Frequency Percentage 
Right 21 42% 
Wrong 29 58% 
Total 50 100% 
 
 
This table shows needle angle was correct in only 42 % patients 
and incorrect in 52 % on first visit. 
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NEEDLE ANGLE – I VISIT 
 
 
 
 
 
 
 
 
 
 
This is diagramatic representation of Needle Angle - First visit. 
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TABLE : 12 
 
DISPOSAL OF SYRINGE – I VISIT 
 
 
 
Disposal of syringe was done correctly only in 2% of patients 
while it was done wrongly by 98 % of patients. 
 
 
 
 
 
 
 
Syringe disposal Frequency Percentage 
Right 1 2% 
Wrong 49 98% 
Total 50 100% 
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DISPOSAL OF SYRINGE – I VISIT 
 
 
 
 
 
 
 
 
 
 
 
This is diagramatic representation of disposal of syringe - First 
visit. 
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TABLE : 13 
 
LIMB ROTATION – I VISIT 
 
Limb rotation Frequency Percentage 
Right 50 100% 
Wrong 0 0% 
 
 
This table shows that limb rotation was practiced correctly in all 
patients at first visit itself. 
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LIMB ROTATION – I VISIT 
 
 
This is diagramatic representation of LimbRotation in - First visit. 
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TABLE : 14 
 
SITE ROTATION—I VISIT 
 
Site Rotation Frequency Percentage 
Right 33 66% 
Wrong 17 34% 
 
 
This table shows only 66% of patients rotated the injection site and 
other 34% did not. 
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This is diagramatic representation of Site Rotation in First visit. 
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TABLE : 15 
 
SITE  RELATED  PROBLEM  - I VISIT 
 
 
Site Problems Frequency Percentage 
None 26 52 % 
Present 24 48 % 
Total 50 100 % 
 
 
52 % of patients did not have any site related problem at first visit, 
but 48% of patients had these problems.  
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SITE  RELATED  PROBLEM - I VISIT 
 
 
This is diagramatic representation of Site Related problem in First 
visit. 
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TABLE : 17 
 
HbA1C – I VISIT 
 
HbA1c range Frequency Percentage 
Good control 23 46 % 
Poor control 27 54 % 
Total 50 100 % 
 
46 % Patients had HbA1C levels within good control range 
while HbA1C levels were outside the range in 54 % patients in first 
visit. 
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HbA1C – I VISIT 
 
 
 
 
 
 
 
 
 
 
 
 
 
This is diagramatic representation of HbA1C – I Visit. 
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TABLE : 18 
 
EFFECT OF COUNSELLING ON PARAMETERS 
SMBG – PRE AND POST COUNSELLING 
SMBG 
Frequency First visit Second visit Third visit 
Weekly Twice 10% 33.3 % 46.7% 
Weekly Once 58% 58.3% 53.3% 
Occasional 32% 8.4% 0 
     
On first visit, SMBG was done weekly twice in only 10% and it 
increased to 33.3% in second visit after first counseling. This increase of 
23.3 % was found to be statistically significant with a p value of 0.001. 
After second counseling, on third visit there was a further increase 
of 13.4 % in SMBG frequency which was also statistically significant (p 
value 0.001). 
Overall, after two counseling sessions, all patients who were 
performing SMBG sub optimally improved with 46.7% performing 
weekly twice, the rest 53.3% performing weekly once and none less 
frequently.  This difference was also statistically significant. 
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This clustered bar chart clearly shows the improvement in 
frequency of monitoring SMBG in every visit. 
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TABLE : 20 
 
LOADING OF INSULIN –PRE AND POST COUSELLING 
Loading of insulin First visit Second visit Third visit 
Right 98% 97.9% 100% 
Wrong 2% 2.1% 0 
 
This table shows loading of order of insulin is high in first visit 
itself, (98 %) and during subsequent visits it increased to 100% at 3rd 
review. Statistically it had no significant p value in all three visits. 
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This chart shows that order of loading of insulin in each visit.  
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TABLE : 21 
 
ACCURACY OF DOSE – PRE AND POST COUNSELLING 
Accuracy of dose First visit Second visit Third visit 
Right 30% 56% 84.4% 
Wrong 70% 40% 15.6% 
 
This table shows accuracy of dose of insulin in each visit. At first 
visit it was only 30%, but in second visit it reached 56 % (the increase in 
percentage is 26 %, with a significant p value of <0.001).  
When comparing second and third visits, increase in percentage is 
28.4 % and this was also statistically significant (p value <0.001).  
While only 30% of patients were correct in accuracy of loading the 
insulin dose on first visit, 84.4% were correct in third visit, amounting to 
increase of 54.4 %.  
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This table shows the change in accuracy of dose in subsequent 
visits following counseling.  
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TABLE : 22 
 
PRE INJECTION SKIN CLEANING – PRE AND POST 
COUNSELLING: 
Skin cleaning First visit Second visit Third visit 
Right 92% 96% 100% 
Wrong 8% 0 0 
 
This table shows that 92 % of patients were correct in not cleaning 
the skin prior to injection on first visit and this increased to 96 % in 
second visit and further increased to 100% in third visit. But statistically 
this does not having a significant p value because increase in percentage 
is small.    
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This table shows that pre skin cleaning percentage is high at basal 
level itself. So increase in percentage during subsequent reviews does not 
have significant p value.  
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TABLE : 23 
 
SKIN PINCH APPROPRIATE – PRE AND POST COUNSELLING 
Skin pinch First visit Second visit Third visit 
Right 52% 79.2% 93.3% 
Wrong 48% 20.08% 6.7% 
 
 This table shows that appropriately done skin pinch was observed 
in 52% patients during 1st visit, on second visit it is further increased to 
79.2% and this has a significant p value of 0.003. 
During 3rd visit it further increased to 93.3% because of 
counseling. The increase in percentage is 14 % and it also has significant 
p value 0.001.  
From basal level of 52 % to 93.3% is reached because of repeated 
counseling. Increase in percentage from first to third visit is 41.3 % and it 
also has significant p value 0.001. 
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This diagram shows the change in skin pinch appropriation 
following counseling in each visit. 
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TABLE : 24 
NEEDLE ANGLE – PRE AND POST COUNSELLING 
Needle angle First visit Second visit Third visit 
Right 42% 64.6% 71.1% 
Wrong 58% 35.4% 28.9% 
 
This table shows needle angling properly followed by 42% of 
patients in first visit which increased to 64.6% during second visit with a 
increase in percentage of 22.6%. This is due to the effect of counseling 
and has a significant p value of 0.005. 
When compared to second visit, third visit had a further increase in 
percentage of 6.4% and has significant p value  <0.001. 
When comparing 1st visit with 3rd visit a total increase of 29.1% is 
observed and it has significant p value (0.005). 
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This chart shows the increase in percentage of correct needle 
angling from 1st visit to 3rd visit. 
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TABLE : 25 
DISPOSAL OF SYRINGE – PRE AND POST COUSELLING 
Syringe disposal First visit Second visit Third visit 
Right 2% 20.8% 62.2% 
Wrong 98% 79.2% 37.8% 
 
This table shows correct disposal of syringe was followed by only 
2% of patients on first visit. It increased to 20.8% at second visit and 
62.2% at 3rd visit (increase in percentage is 60.2%)  
The increase in correct disposal of syringe had a significant p value 
(0.049) when it was compared between first and second visit. 
Significant p value (0.040) was also observed when second visit 
was compared with the third.  
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This chart shows practice of correct disposal of syringe is 
increasing gradually from 1st to 3rd visits. 
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TABLE : 27 
 
LIMB ROTATION – PRE AND POST COUNSELLING 
Limb rotation First Review Second Review Third Review 
Right 100% 97.9% 100% 
Wrong 0 2.1% 0 
 
This table shows that correct practice of limb rotation was 
observed by all of the patients at 1st visit. But this parameter showed a 
slight decline (97.9%) at 2nd visit and again reached 100% at 3rd visit. 
This does not having any significant p value, when comparison was done 
between the visits. 
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This chart shows limb rotation practice of patients on first and 
subsequent visits. 
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TABLE : 28 
 
SITE ROTATION – PRE AND POST COUNSELLING: 
Site rotation First visit Second visit Third visit 
Right 66% 91.7% 97.8% 
Wrong 34% 8.3% 2.2% 
 
The table shows the practice of site rotation in first visit and 
following counseling. 
The increase in site rotation from first to second visit of 25.7% has 
a significant p value of 0.005  
  Increase of 6.7% from second to third visit has a significant p value 
of 0.0011. 
After two counseling’s only 2.2% were not performing site rotation 
correctly. 
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This chart shows site rotation on all visits and depicts the increase 
following counseling.  
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TABLE : 29 
 
SITE RELATED PROBLEMS – PRE AND POST COUNSELLING: 
Site problems First visit Second visit Third visit 
No 52% 64.6% 68.9% 
Yes 48% 35.4% 31.1% 
 
This table shows that site related problems decreased from 48% in 
first visit to 35.4% in the second visit, with a significant p value (<0.001). 
This further decreased to 31.1% in third visit with a significant      
p value (<0.001). 
Overall there was a 16.9% decrease in site related problems. 
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This chart shows the steady decline in site related problems on 
subsequent visits as a result of counseling. 
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TABLE : 30 
HB A1C – PRE AND POST COUNSELLING 
HbA1c Category First visit Second visit Third visit 
Good control 46% 62.5% 77.8% 
Poor control 54% 37.5% 22.2% 
 
This table shows the level of metabolic control in first and 
subsequent visits. On first visit, only 46% had good control which 
increased to 62.5% in second visit and 77.8% in the third visit. 
The increase of 16.5% following first counseling and 15.3% 
following the second counseling were statistically significant with a p 
value of  <0.001in both. 
Overall increase of patients with good control by 31.8% was also 
statistically significant with p value <0.001.  
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This chart shows percentage of patients with good and poor 
metabolic control on first and subsequent visits following counseling. 
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DISCUSSION  
 
The incidence of type 1 diabetes is increasing worldwide especially 
in younger children. Unfortunately, there is little information on the 
incidence of type 1 diabetes and its management from India. Recent 
studies have emphasized the importance of strict glycemic control in the 
prevention and delay of chronic micro vascular complications of diabetes 
mellitus. These are few pediatricians and even fewer diabetes nurse 
educators trained in management of type 1 diabetes. This study  to 
evaluate   the  problems   in    home  based  insulin therapy   and  effect  
of  counseling  in   type 1 diabetic patients 
AGE   GROUP  
 
The predominant age   group in the study population was 5 to 9 
years. 60 percentages of the patients belong to this age group in this study 
which is the most commonly involved age group. 
  
GENDER  
 Female sex is involved more often than male sex in this study 
(64% as against 36%), but according to north American journal, both 
genders are equally affected and there is no gender  preponderance .  
 
 100 
 
DURATION OF ILLNESS 
 Highest percentages of patients were diagnosed with diabetes 12 
to 18 months before. Newly diagnosed patients who were diagnosed less 
than 18 months were only included in the study as this is the period 
during which the patient as well as parent would be new to the concept of 
home treatment with injections and will need periodic reinforcement of 
the information provided at diagnosis. As time passes by they get adapted 
and trained to monitoring SMBG and appropriate injection techniques. 
 
BODY MASS INDEX (BMI)  
Most of the patients belong to normal BMI i.e.  90 % and none 
were in under nutrition category. 
 
PARENTAL EDUCATION   
Most parents had studied upto HSC followed by uneducated, while 
least number had done their graduation. 
 
SELF MONITORING OF BLOOD GLUCOSE   
On first visit self monitoring of blood glucose was done twice 
weekly by only 10% of patients which increased steadily following the 
two counseling sessions and was 46.7% at third visit. 
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Similarly patients doing SMBG occasionally declined steadily 
from 32% to none. These changes were statistically significant clearly 
showing the usefulness of the counseling given. 
 
LOADING   OF INSULIN   
In this study 98% of patients were loading insulin in correct order 
on their first visit itself. This indicates that this aspect is well understood 
by the patients and may not warrant periodic reinforcement on subsequent 
visits. 
  
ACCURACY OF THE DOSE     
The accuracy of insulin dose was poorly understood and was hence 
inaccurate in most of the patients in this study which steadily increased 
with each counseling. 
Even after two counseling and demonstration sessions, only 84.4 % 
of patients loaded insulin in correct dose and hence according to this 
study patients need some more counseling and demonstration on this 
parameter to reduce their errors. 
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PRE SKIN CLEANING  
Most of  the  patients  have correctly given the insulin without any 
pre skin cleaning at first visit itself and this point is clearly understood by 
them and do not need any further counseling & clarification on this  
parameter . 
 
SKIN PINCH APPROPRIATE   
Only half of the patients had performed skin pinch appropriately in 
their first visit, but following the counseling and demonstration sessions, 
more patients, but not all performed it correctly. This parameter too needs 
more clarification to reduce their errors. 
 
NEEDLE ANGLE  
Less than half of patients gave insulin injection in right angle on 
first visit, but this increased gradually with counseling and demonstration 
and reached 71.1% which is still suboptimal. Hence this aspect needs 
more demonstration to correct the errors. According to Sanjay Karla 
correct technique of injection not only reduces the local complications but 
is also helpful for metabolic control.  
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DISPOSAL OF SYRINGE   
Only 2% of patients disposed the syringe in proper way on first 
visit, which increased to 62.2 % after two counseling sessions. Bio 
medical waste disposal is an important tool for prevention of serious 
infections and cannot be ignored. 
 
LIMB ROTATION   
This aspect is well understood and practiced by most of the 
patients. . 
 
SITE ROTATION   
This aspect also improved significantly with repeated counseling 
which is very important to prevent site related problems. 
 
SITE RELATED PROBLEMS   
The incidence of site related problems declined from half to one 
third of patients following two counseling and demonstration sessions. 
Site related problems like ecchymosis, lipohypertropy, atropy may cause  
not only disfigurement, but also painful injection and poor glycemic  
control leading to long term complications.  
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HIGHLIGHTS AND LIMITATIONS 
 This is a well planned and executed study covering many practical 
aspect of diabetes management, first of its kind in our population. 
 Limitations are small sample size and limited number of 
counseling sessions. 
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SUMMARY 
According to this study the problems of home based insulin 
therapies are    
1) SMBG – not done at optimal frequency in 90%.  
2) Accuracy of loading - Correct in only 30%  
3) Skin pinch appropriation – Correct in 52%   
4) Needle angle – Correct in 42% 
 5) Disposal of syringe – Correct in only 2%  
6) Site rotation – Correct in only 66%   
7) Site related problems – Present in 48%   
8) HBA1C - Good control in only 46%  
 
Aspects which were found to be non problematic were  
1. Order of loading insulin 
2. Pre skin cleaning 
3. Limb rotation. 
Counseling and demonstration resulted in statistically 
significant improvement in all the deficient parameters. But the 
improvement was suboptimal; meaning none of the parameters reached 
100%. This emphasizes the need for continued counseling and 
demonstration on all visits to the diabetic clinic. 
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CONCLUSION 
The final conclusions derived from the study are 
1. The problems of home based therapy are identified namely 
SMBG frequency, accuracy of dose, needle angle, skin pinch, local  
site  related   problem,  site rotation and HBA1C control. 
2. These problems improve significantly with counseling and 
demonstration. Hence the need for continued diabetes education is 
obvious. 
3. Non problematic aspects of home based insulin therapy are order 
of loading insulin, prior skin cleaning, limb rotation and site 
rotation. 
 
This study emphasizes the need for counseling by qualified 
personnel devoting plenty of time with both oral and video 
demonstrations to improve the quality and longevity of life of juvenile 
diabetics.   
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INFORMED CONSENT FORM 
 
Study place: INSTITUTE OF CHILD HEALTH AND HOSPITAL FOR 
CHILDREN, DIABETOLOGY OPD & MEDICAL WARDS. 
Title of the study: “Evaluation of Home way insulin   therapy   and its  
compliance”                                    
Name of the investigator:  Dr.N.Soundararajan     
Name of the Participant:  Age:   Sex: 
Hospital number:    
    
1. I have read and understood this consent form and the information provided to 
me regarding the  
2.  I have had the consent document explained to me.  
3.  I have been explained about the nature of the study.  
4.  I have been explained about my rights and responsibilities by the investigator. 
5. I will allow my child to undergo blood tests  during the study whole heartedly.   
6.  I have informed the investigator of all the treatments my chikd is taking or have 
taken in the past including any native (alternative) treatment.  
7.  I have been advised about the risks associated with my child’s participation in 
this study.* 
8. I agree to cooperate with the investigator and I will inform him/her 
immediately if my child suffer unusual symptoms. * 
9. I have not participated in any research study in the past. 
10. I am aware of the fact that my child can opt out of the study at any time without 
having to give any reason and this will not affect my child’s future treatment in 
this hospital. * 
11. I am also aware that the investigator may terminate my child’s participation in 
the study at any time, for any reason, without my consent. * 
12. I hereby give permission to the investigators to release the information obtained 
from my child as result of participation in this study to the sponsors, regulatory 
  
authorities, Govt. agencies, and IEC. I understand that they are publicly 
presented.  
13. I have understand that  my child’s  identity will be kept confidential if my data 
are publicly presented  
14. I have had my questions answered to my satisfaction.  
15. I have decided to be in the research study.  
 I am aware that if I have any question during this study, I should contact the 
investigator. By signing this consent form I attest that the information given in this 
document has been clearly explained to me and understood by me, I will be given a 
copy of this consent document.  
Name and signature / thumb impression of the parents/guardian  
Name _________________________ Signature_________________ 
Date________________  
Name and Signature of impartial witness:  
Name _________________________ Signature_________________ 
Date________________ 
Name and Signature of the investigator or his representative obtaining consent:  
Name _________________________ Signature_________________ 
Date________________  
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